142937-50-6 Usage
Description
TRIPTOQUINONEB, also known as an abietane diterpenoid, is a chemical compound with the formula C20H26O4. It was originally isolated from Tripterygium wilfordii, a plant with significant medicinal properties. TRIPTOQUINONEB is characterized by its unique molecular structure and potential therapeutic applications.
Uses
Used in Pharmaceutical Industry:
TRIPTOQUINONEB is used as a pharmaceutical compound for its potential therapeutic effects. It is derived from a plant with a history of medicinal use, and its unique chemical structure suggests that it may have various applications in the development of new drugs and treatments.
Used in Research and Development:
In the field of research and development, TRIPTOQUINONEB serves as a valuable compound for studying its properties and potential interactions with other molecules. This can lead to a better understanding of its mechanisms of action and the discovery of new applications in medicine and other industries.
Used in Traditional Medicine:
TRIPTOQUINONEB is also used in traditional medicine, where it is derived from Tripterygium wilfordii, a plant with a long history of use in various cultures. Its inclusion in traditional remedies may provide insights into its potential benefits and uses in modern medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 142937-50-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,2,9,3 and 7 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 142937-50:
(8*1)+(7*4)+(6*2)+(5*9)+(4*3)+(3*7)+(2*5)+(1*0)=136
136 % 10 = 6
So 142937-50-6 is a valid CAS Registry Number.
142937-50-6Relevant articles and documents
Enantiocontrolled total synthesis of the diterpenoids, triptoquinone B, C and triptocallol
Yamamura, Itsuki,Fujiwara, Yoko,Yamato, Toshihiro,Irie, Osamu,Shishido, Kozo
, p. 4121 - 4124 (2007/10/03)
An efficient and enantiocontrolled synthesis of triptoquinone B and C, which possess interleukin-1 inhibitory activity, has been accomplished employing the lipase-catalyzed kinetic resolution and a highly diastereoselective radical cyclization as key synthetic steps. In addition, the first total synthesis of triptocallol has been achieved utilizing the same strategy.
